Saturday, July 11, 2026

Drug profile · INN

hemay020

hemay020 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — hemay020
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

hemay020 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN hemay020

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Hemay020 Phase 1 · Tianjin Hemay Pharmaceutical · Neoplasms,Non-Small Cell Lung Cancer

Frequently asked questions

What is hemay020?

hemay020 is an FDA-listed pharmaceutical active ingredient.